FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

232 hedge funds and large institutions have $2.69B invested in Fate Therapeutics in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 95 increasing their positions, 70 reducing their positions, and 38 closing their positions.

Holders
232
Holders Change
-17
Holders Change %
-6.83%
% of All Funds
3.92%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.15%
New
25
Increased
95
Reduced
70
Closed
38
Calls
$4.17M
Puts
$3.19M
Net Calls
+$987K
Net Calls Change
-$2.94M

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$204M
2
State Street
2
State Street
Massachusetts
$131M
3
Goldman Sachs
3
Goldman Sachs
New York
$26.9M
4
PAMS
4
Pictet Asset Management (Switzerland)
Switzerland
$52.1M
5
AG
5
Artal Group
Luxembourg
$64.4M

Top Sellers

1
CC
1
Casdin Capital
New York
$52M
2
Invesco
2
Invesco
Georgia
$1.18M
3
TLP
3
Tri Locum Partners
New York
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$35M
5
AWA
5
Artemis Wealth Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FHA
276
First Horizon Advisors
Tennessee
$0 8 +8 New
GWS
277
Glassman Wealth Services
Virginia
$0 12 +12 New
8 9 10 11
12